表紙
市場調查報告書
商品編碼
1033261

全球藥物警戒市場:臨床試驗階段、方法、服務提供商、工藝流程、治療領域、最終用戶、地區-預測和機會 (2026)

Global Pharmacovigilance Market, By Clinical Trial Phase, By Method, By Service Provider, By Process Flow, By Therapeutic Area, By End-User, By Region, Forecast & Opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

在全球藥物消費量增加和藥物開發進展的背景下,預計全球藥物警戒市場在預測期內將錄得兩位數的複合年增長率。隨著癌症和糖尿病等慢性病的增多,對先進有效藥物的需求也在增加。鑑於藥物不良事件 (ADR) 的可能性,醫療機構繼續實施藥物警戒服務。此外,各地區消費者保護法的頒布也支持了市場的增長。

本報告探討了全球藥物警戒市場、產品概述、新型冠狀病毒感染(COVID-19)的市場影響、細分(臨床試驗階段、方法、服務提供商、工藝流程、治療領域)、最終用戶)市場規模和預測主要地區/國家的市場份額、主要地區/國家的詳細趨勢、促進市場增長的因素和挑戰、市場趨勢、競爭形勢、主要公司簡介等。

目錄

第 1 章產品概述

第二章調查方法

第 3 章 COVID-19 對全球藥物警戒市場的影響

第 4 章執行摘要

第五章客戶反饋

第 6 章全球藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段(臨床前、I 期、II 期、III 期、IV 期)
    • 按方法(自願報告、增強的不良事件 (ADR) 報告、有針對性的自願報告、隊列事件監測、EHR 挖掘)
    • 按服務提供商(內部、合同外包)
    • 按流程(案例數據管理、信號檢測、風險管理系統)
    • 按治療領域(腫瘤學、神經學、心臟病學等)
    • 按最終用戶(製藥/生物技術公司、醫療設備製造商等)
    • 按公司 (2021)
    • 按地區
  • 產品市場地圖

第七章亞太地區藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段
    • 按方法
    • 按服務提供商
    • 按流程
    • 按治療領域
    • 最終用戶
    • 按國家/地區
  • 亞太地區:國家分析
    • 中國藥物警戒市場展望
    • 印度藥物警戒市場展望
    • 日本藥物警戒市場展望
    • 韓國藥物警戒市場展望
    • 澳大利亞藥物警戒市場展望

第 8 章歐洲藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段
    • 按方法
    • 按服務提供商
    • 按流程
    • 按治療領域
    • 最終用戶
    • 按國家/地區
  • 歐洲:國家分析
    • 法國藥物警戒市場展望
    • 德國藥物警戒市場展望
    • 英國藥物警戒市場展望
    • 意大利藥物警戒市場展望
    • 西班牙藥物警戒市場展望

第 9 章北美藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段
    • 按方法
    • 按服務提供商
    • 按流程
    • 按治療領域
    • 最終用戶
    • 按國家/地區
  • 北美:國家分析
    • 美國藥物警戒市場展望
    • 墨西哥藥物警戒市場展望
    • 加拿大藥物警戒市場展望

第 10 章南美藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段
    • 按方法
    • 按服務提供商
    • 按流程
    • 按治療領域
    • 最終用戶
    • 按國家/地區
  • 南美洲:國家分析
    • 巴西藥物警戒市場展望
    • 阿根廷藥物警戒市場展望
    • 哥倫比亞藥物警戒市場展望

第 11 章中東和非洲藥物警戒市場展望

  • 市場規模和預測
  • 市場份額及預測
    • 按臨床試驗階段
    • 按方法
    • 按服務提供商
    • 按流程
    • 按治療領域
    • 最終用戶
    • 按國家/地區
  • 中東/非洲:國家分析
    • 南非藥物警戒市場展望
    • 沙特阿拉伯的藥物警戒市場展望
    • 阿拉伯聯合酋長國藥物警戒市場展望

第 12 章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢與發展

第14章競爭形勢

  • 競爭前景
  • 公司簡介
    • IBM Corporation
    • Accenture Plc
    • Linical Accelovance
    • Cognizant Technology Solutions Corporation
    • Laboratory Corporation of America Holdings
    • ArisGlobal LLC
    • ICON plc
    • Capgemini SE
    • Parexel International Corporation
    • Wipro Ltd
    • United BioSource Corporation
    • BioClinica Inc.
    • TAKE Solutions Ltd.
    • ITClinical
    • Foresight Group International AG

第 15 章戰略建議

第 16 章關於我們和免責聲明

目錄
Product Code: 4809

Global pharmacovigilance market is anticipated to witness double digit CAGR during the forecast period owing to the increasing drug consumption and drug developments around the globe. Growing prevalence of chronic diseases such as oncology, diabetes, and others has created the need for advanced and more effective pharmaceutical drugs. Keeping in view the chances of Adverse Drug Reactions (ADR) and drug toxicity, healthcare companies are continuously incorporating pharmacovigilance services. Moreover, numerous consumer health protection acts across various regions are further propelling the growth of this market.

Pharmacovigilance is concerned with identifying the hazards associated with pharmaceutical products and minimizing the risk of any harm that may come to patients. The service helps in finding the new safety concerns and evaluating the already known risks. It also helps in keeping a watch on the benefit risk balance of a drug. Any change in the benefit risk ratio will alter the safety profile of the drug.

Global pharmacovigilance market can be segmented based on clinical trial phase, method, service provider, end-user and region. Based on service provider, the market is categorized into in-house and contract outsourcing. Among them, the contract outsourcing service provider dominated the market in 2020 and is expected to dominate the market during the forecast period owing to the fact that it eliminates the risk of business overhead costs and is thus, being increasingly adopted by healthcare companies

Regionally, Asia-Pacific dominates the market and is expected to undergo highest CAGR until 2026 owing to stringent healthcare regulations across the region. The region has also a large patient pool, which is leading to increasing number of clinical trials. Also, countries such as India and China have large clinical research spaces and offer attractive opportunities to healthcare companies.

Major companies operating in global pharmacovigilance market include IBM Corporation, Accenture Plc, Linical Accelovance, Cognizant Technology Solutions Corporation, Laboratory Corporation of America Holdings, ArisGlobal LLC, ICON plc, Capgemini SE, Parexel International Corporation, Wipro Ltd, United BioSource Corporation, BioClinica Inc., TAKE Solutions Ltd., ITClinical, Foresight Group International AG and others. The companies are focusing on research and development activities to offer better pharmacovigilance services and increase their global market share.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global pharmacovigilance market.
  • To forecast global pharmacovigilance market based on clinical trial phase, method, service provider, end-user, company and regional distribution.
  • To identify drivers and challenges for global pharmacovigilance market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global pharmacovigilance market.
  • To identify and analyze the profile of leading players operating in the global pharmacovigilance market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research.

TechSci Research calculated global pharmacovigilance market size using a bottom-up approach, where data for various end user industries and its application across various product types was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Pharmacovigilance service providers, pharmaceutical companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to pharmacovigilance
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmacovigilance companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global pharmacovigilance market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Pharmacovigilance Market, By Clinical Trial Phase:

Pre-Clinical

Phase 1

Phase 2

Phase 3

Phase 4

  • Global Pharmacovigilance Market, By Method:

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

  • Global Pharmacovigilance Market, By Service Provider:

In-House

Contract Outsourcing

  • Global Pharmacovigilance Market, By Process Flow :

Case Data Management

Signal Detection

Risk Management System

  • Global Pharmacovigilance Market, By Therapeutic Area

Oncology

Neurology

Cardiology

Others

  • Global Pharmacovigilance Market, By End-User:

Pharmaceutical & Biotechnology Companies

Medical Device Manufacturers

Others

  • Global Pharmacovigilance Market, By Region:

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global pharmacovigilance market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Pharmacovigilance Market

4. Executive Summary

5. Voice of Customer

6. Global Pharmacovigilance Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4)
    • 6.2.2. By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining)
    • 6.2.3. By Service Provider (In-House, Contract Outsourcing)
    • 6.2.4. By Process Flow (Case Data Management, Signal Detection, Risk Management System)
    • 6.2.5. By Therapeutic Area (Oncology, Neurology, Cardiology, Others)
    • 6.2.6. By End-User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Others)
    • 6.2.7. By Company (2021)
    • 6.2.8. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Pharmacovigilance Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Clinical Trial Phase
    • 7.2.2. By Method
    • 7.2.3. By Service Provider
    • 7.2.4. By Process Flow
    • 7.2.5. By Therapeutic Area
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Pharmacovigilance Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Clinical Trial Phase
        • 7.3.1.2.2. By Method
        • 7.3.1.2.3. By Service Provider
        • 7.3.1.2.4. By End-User
    • 7.3.2. India Pharmacovigilance Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Clinical Trial Phase
        • 7.3.2.2.2. By Method
        • 7.3.2.2.3. By Service Provider
        • 7.3.2.2.4. By End-User
    • 7.3.3. Japan Pharmacovigilance Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Clinical Trial Phase
        • 7.3.3.2.2. By Method
        • 7.3.3.2.3. By Service Provider
        • 7.3.3.2.4. By End-User
    • 7.3.4. South Korea Pharmacovigilance Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Clinical Trial Phase
        • 7.3.4.2.2. By Method
        • 7.3.4.2.3. By Service Provider
        • 7.3.4.2.4. By End-User
    • 7.3.5. Australia Pharmacovigilance Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Clinical Trial Phase
        • 7.3.5.2.2. By Method
        • 7.3.5.2.3. By Service Provider
        • 7.3.5.2.4. By End-User

8. Europe Pharmacovigilance Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Clinical Trial Phase
    • 8.2.2. By Method
    • 8.2.3. By Service Provider
    • 8.2.4. By Process Flow
    • 8.2.5. By Therapeutic Area
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Pharmacovigilance Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Clinical Trial Phase
        • 8.3.1.2.2. By Method
        • 8.3.1.2.3. By Service Provider
        • 8.3.1.2.4. By End-User
    • 8.3.2. Germany Pharmacovigilance Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Clinical Trial Phase
        • 8.3.2.2.2. By Method
        • 8.3.2.2.3. By Service Provider
        • 8.3.2.2.4. By End-User
    • 8.3.3. United Kingdom Pharmacovigilance Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Clinical Trial Phase
        • 8.3.3.2.2. By Method
        • 8.3.3.2.3. By Service Provider
        • 8.3.3.2.4. By End-User
    • 8.3.4. Italy Pharmacovigilance Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Clinical Trial Phase
        • 8.3.4.2.2. By Method
        • 8.3.4.2.3. By Service Provider
        • 8.3.4.2.4. By End-User
    • 8.3.5. Spain Pharmacovigilance Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Clinical Trial Phase
        • 8.3.5.2.2. By Method
        • 8.3.5.2.3. By Service Provider
        • 8.3.5.2.4. By End-User

9. North America Pharmacovigilance Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Clinical Trial Phase
    • 9.2.2. By Method
    • 9.2.3. By Service Provider
    • 9.2.4. By Process Flow
    • 9.2.5. By Therapeutic Area
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Pharmacovigilance Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Clinical Trial Phase
        • 9.3.1.2.2. By Method
        • 9.3.1.2.3. By Service Provider
        • 9.3.1.2.4. By End-User
    • 9.3.2. Mexico Pharmacovigilance Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Clinical Trial Phase
        • 9.3.2.2.2. By Method
        • 9.3.2.2.3. By Service Provider
        • 9.3.2.2.4. By End-User
    • 9.3.3. Canada Pharmacovigilance Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Clinical Trial Phase
        • 9.3.3.2.2. By Method
        • 9.3.3.2.3. By Service Provider
        • 9.3.3.2.4. By End-User

10. South America Pharmacovigilance Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Clinical Trial Phase
    • 10.2.2. By Method
    • 10.2.3. By Service Provider
    • 10.2.4. By Process Flow
    • 10.2.5. By Therapeutic Area
    • 10.2.6. By End-User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmacovigilance Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Clinical Trial Phase
        • 10.3.1.2.2. By Method
        • 10.3.1.2.3. By Service Provider
        • 10.3.1.2.4. By End-User
    • 10.3.2. Argentina Pharmacovigilance Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Clinical Trial Phase
        • 10.3.2.2.2. By Method
        • 10.3.2.2.3. By Service Provider
        • 10.3.2.2.4. By End-User
    • 10.3.3. Colombia Pharmacovigilance Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Clinical Trial Phase
        • 10.3.3.2.2. By Method
        • 10.3.3.2.3. By Service Provider
        • 10.3.3.2.4. By End-User

11. Middle East and Africa Pharmacovigilance Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Clinical Trial Phase
    • 11.2.2. By Method
    • 11.2.3. By Service Provider
    • 11.2.4. By Process Flow
    • 11.2.5. By Therapeutic Area
    • 11.2.6. By End-User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Pharmacovigilance Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Clinical Trial Phase
        • 11.3.1.2.2. By Method
        • 11.3.1.2.3. By Service Provider
        • 11.3.1.2.4. By End-User
    • 11.3.2. Saudi Arabia Pharmacovigilance Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Clinical Trial Phase
        • 11.3.2.2.2. By Method
        • 11.3.2.2.3. By Service Provider
        • 11.3.2.2.4. By End-User
    • 11.3.3. UAE Pharmacovigilance Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Clinical Trial Phase
        • 11.3.3.2.2. By Method
        • 11.3.3.2.3. By Service Provider
        • 11.3.3.2.4. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. IBM Corporation
    • 14.2.2. Accenture Plc
    • 14.2.3. Linical Accelovance
    • 14.2.4. Cognizant Technology Solutions Corporation
    • 14.2.5. Laboratory Corporation of America Holdings
    • 14.2.6. ArisGlobal LLC
    • 14.2.7. ICON plc
    • 14.2.8. Capgemini SE
    • 14.2.9. Parexel International Corporation
    • 14.2.10. Wipro Ltd
    • 14.2.11. United BioSource Corporation
    • 14.2.12. BioClinica Inc.
    • 14.2.13. TAKE Solutions Ltd.
    • 14.2.14. ITClinical
    • 14.2.15. Foresight Group International AG

15. Strategic Recommendations

16. About Us & Disclaimer